HIGHLIGHTS
- who: Hiroshi Hisanaga and colleagues from the Department of Medicine, Division of Gastroenterology, Kurume University School of Medicine, Kurume, Fukuoka, Japan have published the article: Effect of Direct-Acting Antiviral Agents on Gastroesophageal Varices in Patients with Hepatitis C Virus-Related Cirrhosis, in the Journal: Medicina 2022, 58, 1077. of 10/08/2022
- what: The authors assessed whether DAA-induced HCV eradication reduced the risk of of GEV development during follow-up in patients with HCV-related LC. Through a multivariate analysis, Yuri et_al revealed that patients who had GEVs with forms of grade F2 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.